...technology detects biomarkers in breast nipple aspirate fluid. In January, the university granted Halo (formerly NeoMatrix LLC...

...in a diagnostic assay. The technology is based on biomarkers from breast nipple aspirate fluid. NeoMatrix...
...in cancer diagnostics. The parties can extend the option in mid-2012. Details were not disclosed. NeoMatrix LLC...